BSE Live
Apr 13, 16:00Prev. Close
57.09
Open Price
58.51
Bid Price (Qty.)
56.10 (30)
Offer Price (Qty.)
61.50 (58)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Aspira Pathlab & Diagnostics (in Rs. Cr.) | Mar 25 | Mar 24 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 1.97 | -2.60 | |
| Diluted EPS (Rs.) | 1.97 | -2.60 | |
| Cash EPS (Rs.) | 3.46 | -1.10 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 7.03 | 5.07 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 7.03 | 5.07 | |
| Revenue from Operations/Share (Rs.) | 21.37 | 12.83 | |
| PBDIT/Share (Rs.) | 3.80 | -0.74 | |
| PBIT/Share (Rs.) | 2.35 | -2.24 | |
| PBT/Share (Rs.) | 2.01 | -2.60 | |
| Net Profit/Share (Rs.) | 2.01 | -2.60 | |
| NP After MI And SOA / Share (Rs.) | 1.97 | -2.60 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 17.79 | -5.79 | |
| PBIT Margin (%) | 11.00 | -17.45 | |
| PBT Margin (%) | 9.42 | -20.23 | |
| Net Profit Margin (%) | 9.42 | -20.23 | |
| NP After MI And SOA Margin (%) | 9.19 | -20.23 | |
| Return on Networth/Equity (%) | 27.94 | -51.25 | |
| Return on Capital Employed (%) | 16.03 | -18.23 | |
| Return on Assets (%) | 11.58 | -18.16 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 1.37 | 0.00 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 2.26 | 2.10 | |
| Quick Ratio (X) | 2.05 | 1.89 | |
| Inventory Turnover Ratio (X) | 45.90 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | |
| Coverage Ratios | |||
| Interest Coverage Ratios (%) | 11.27 | -2.08 | |
| Interest Coverage Ratios (Post Tax) (%) | 11.27 | -2.08 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 86.79 | 31.60 | |
| EV/Net Operating Revenue (X) | 3.95 | 2.39 | |
| EV/EBITDA (X) | 22.18 | -41.27 | |
| MarketCap/Net Operating Revenue (X) | 3.99 | 2.42 | |
| Retention Ratios (%) | 0.00 | 0.00 | |
| Price/BV (X) | 12.12 | 6.12 | |
| Price/Net Operating Revenue | 3.99 | 2.42 | |
| Earnings Yield | 0.02 | -0.08 |
25.02.2026
Aspira Pathlab Standalone December 2025 Net Sales at Rs 5.12 crore, down 5.34% Y-o-Y
13.08.2025
Aspira Pathlab Consolidated June 2025 Net Sales at Rs 5.25 crore, up 13.17% Y-o-Y
19.05.2025
Aspira Pathlab Standalone March 2025 Net Sales at Rs 5.78 crore, up 51.31% Y-o-Y
10.02.2025
Aspira Pathlab Standalone December 2024 Net Sales at Rs 5.41 crore, up 56.21% Y-o-Y